Search Within

Kenneth Ho-Ming Yu

Formats
  1. Meeting Abstract (81)
  2. Journal Article (78)
  3. Review (2)
  4. Book Section (1)
  5. Conference Paper (1)
Groups
  1. Center for Pancreatic Cancer Research (163)
  2. Department of Medicine (163)
  3. Gastrointestinal Oncology Service (163)
  4. Solid Tumor Oncology Division (163)
  5. Epidemiology and Biostatistics (57)
  6. GSK Faculty (57)

More Groups

People
  1. Eileen O'Reilly (120)
  2. Maeve Lowery (52)
  3. Anna Varghese (50)
  4. David Kelsen (44)
  5. Marinela Capanu (44)
  6. Wungki Park (33)

More People

Years
  1. 2025 (1)
  2. 2024 (10)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (14)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (67)
  2. Clinical Cancer Research (9)
  3. Cancer (8)
  4. Cancers (6)
  5. Annals of Oncology (4)
  6. Cancer Medicine (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (68)
  2. American Association for Cancer Research (15)
  3. Wiley Blackwell (14)
  4. Elsevier Inc. (10)
  5. Oxford University Press (10)
  6. MDPI (7)

More Publishers

Results (163)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Weighing the risks and benefits of neoadjuvant therapy in resectable pancreatic cancer: Neoadjuvant therapy should not be used as part of standard clinical practice
    Journal Article

    Elarre, P. S.; Yu, K. H.
    Oncology (Norwalk) (2018)

    Fulltext@MSK | Save
  • HuMab-5B1 (MVT-5873), a mAb targeting sLe(a), in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies
    Meeting Abstract

    O'Reilly, E. M.; Borazanci, E. H.; Yu, K. H.; Varghese, A. M.; Estrella, H.; Kamins, D.; Melink, T.; Dorr, K.; Maffuid, P.; Gutheil, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective analysis of somatic and germline genetic alterations in patients with ampullary carcinomas
    Meeting Abstract

    Wong, W.; O'Reilly, E. M.; Varghese, A. M.; Yu, K. H.; Iacobuzio-Donahue, C. A.; Shia, J.; Klimstra, D.; Allen, P. J.; Lowery, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Tsui, D.; Lowery, M. A.; Capanu, M.; Yu, K. H.; Kelsen, D. P.; Gedvilaite, E.; Zhang, L.; Selcuklu, S. D.; You, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genome wide cis-regulatory elements accessibility signature predicts early recurrence of the treatment-naïve resected subset of PDAC: A new paradigm for precision oncology
    Meeting Abstract

    Dhara, S.; Chhangawala, S.; Askan, G.; Liguo, Z.; Sinha, S.; Glassman, D.; Yu, K.; Balachandran, V.; Leslie, C.; Leach, S.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
    Meeting Abstract

    Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma
    Conference Paper

    Yu, K.
    Millennium Medical Publishing, Inc (2018)

    Fulltext@MSK | Save
  • Nano-liposomal irinotecan and 5-FU/LV (N+F) for the treatment of advanced PDAC: Memorial Sloan Kettering (MSK) single cancer center evaluation
    Meeting Abstract

    Glassman, D. C.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor and invasive cell gene expression profile predicts treatment response and survival in pancreatic adenocarcinoma
    Journal Article

    Yu, K. H.; Ricigliano, M.; McCarthy, B.; Chou, J. F.; Capanu, M.; Cooper, B.; Bartlett, A.; Covington, C.; Lowery, M. A.; O’Reilly, E. M.
    Cancers (2018)

    Fulltext@MSK | Save